-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--SVB Securities Adjusts Price Target on AbCellera Biologics to $18 From $20, Maintains Outperform Rating

--SVB Securities Adjusts Price Target on AbCellera Biologics to $18 From $20, Maintains Outperform Rating

MT Newswires · 01/06/2023 06:00